Prognostic significance of PCR-based molecular staging in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy
- 9 June 2016
- journal article
- other
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 58 (2) , 357-365
Abstract
The prognostic role of detecting clonal immunoglobulin gene rearrangement (IgR) from bone marrow (BM) aspirates was evaluated by BIOMED-2 PCR in 97 patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab-CHOP immunochemotherapy. Sixteen (16.5%) patients had BM involvement (BMI) defined by BM biopsy (MOR+) and 39 (40.2%) had positive IgR (PCR+). Patients with MOR + BMI showed inferior event-free survival (EFS) compared to those with MOR−/PCR− (p < 0.001) or those with MOR−/PCR + BMI (p = 0.002), while no significant difference in EFS was observed between patients with MOR−/PCR + and those with MOR−/PCR − BMI (p = 0.497). Use of the BIOMED-2 for PCR resulted in significant increase in detection of BMI. However, the increased sensitivity by PCR did not translate into improved prediction of prognosis, emphasizing the essential role of histopathological review of trephine biopsy for the detection of BMI.Keywords
Funding Information
- Gachon University Gil Medical Center (2013-07)
This publication has 20 references indexed in Scilit:
- Clinical implications and prognostic role of minimal residual disease detection in follicular lymphomaTherapeutic Advances in Hematology, 2013
- EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferationsLeukemia, 2012
- Bone Marrow Aspiration and BiopsyNew England Journal of Medicine, 2009
- Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot studyPathology, 2007
- Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)Leukemia, 2004
- Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphomaBlood, 2002
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Correlation of PCR-Detected Clonal Gene Rearrangements with Bone Marrow Morphology in Patients with B-Lineage LymphomasAmerican Journal of Surgical Pathology, 1997
- Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma.Journal of Clinical Pathology, 1990
- Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid NeoplasmsNew England Journal of Medicine, 1983